Trial Profile
NAFLD in T2DM: Prevalence in Hispanics and Role of Treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary) ; Vitamin E
- Indications Non-alcoholic steatohepatitis; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 06 Apr 2017 Status changed from active, no longer recruiting to completed.
- 01 Sep 2016 Planned End Date changed from 1 Dec 2017 to 1 Dec 2016.
- 05 Aug 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.